Facilities
Vaxco Pharmaceuticals has entered into a contractual agreement with Hope Cancer Institute to lease space in its outpatient cancer treatment facility located in Kansas City, Kansas. Many of the clinical trials sponsored by Vaxco Pharmaceuticals will be conducted at Hope Cancer Institute.
The campus is nearly 6000 square feet and sits on 2.2 wooded acres. The open and airy design of the building ensures each patient enrolled in a clinical trial a comfortable, quiet atmosphere to receive his or her cancer treatment in the utmost relaxed environment. Patients have the opportunity to visit with each other during their stay and friends and family are always welcome.
Laboratory research, animal studies and vaccine production for Vaxco Pharmaceuticals are conducted off site. Oral mucositis products along with other oral care products are produced on site.